Business · 30/05/2025Updated: 10/17/2026 · 1 min read
FDA Announces Annual Report on Postmarketing Requirements and Commitments for Drug and Biologics Firms
Summary
The FDA has released its annual report on the performance of drug and biologics firms in conducting postmarketing requirements and commitments, as mandated by the Federal Food, Drug, and Cosmetic Act.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →